Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

First Report of Fludioxonil Resistance in Botrytis cinerea, the Causal Agent of Gray Mold, from Strawberry Fields in Maryland and South Carolina.

Fernández-Ortuño D, Grabke A, Bryson PK, Rouse RJ, Rollins P, Schnabel G.

Plant Dis. 2014 May;98(5):692. doi: 10.1094/PDIS-08-13-0875-PDN.

PMID:
30708511
2.

Development and application of a microarray meter tool to optimize microarray experiments.

Rouse RJ, Field K, Lapira J, Lee A, Wick I, Eckhardt C, Bhasker CR, Soverchia L, Hardiman G.

BMC Res Notes. 2008 Jul 11;1:45. doi: 10.1186/1756-0500-1-45.

3.

PatGen--a consolidated resource for searching genetic patent sequences.

Rouse RJ, Castagnetto J, Niedner RH.

Bioinformatics. 2005 Apr 15;21(8):1707-8. Epub 2005 Feb 22.

PMID:
15728120
4.

Development of a microarray assay that measures hybridization stoichiometry in moles.

Rouse RJ, Espinoza CR, Niedner RH, Hardiman G.

Biotechniques. 2004 Mar;36(3):464-70.

5.

Influence of CCR7 ligand DNA preexposure on the magnitude and duration of immunity.

Lee Y, Eo SK, Rouse RJ, Rouse BT.

Virology. 2003 Jul 20;312(1):169-80.

6.

Herpes simplex virus-enhanced cationic lipid/DNA-mediated transfection.

Rouse RJ, Seifried W, Mistry SK, Goins WF, Glorioso JC.

Biotechniques. 2000 Oct;29(4):810-4.

7.

Involvement of an ATP-dependent peptide chaperone in cross-presentation after DNA immunization.

Kumaraguru U, Rouse RJ, Nair SK, Bruce BD, Rouse BT.

J Immunol. 2000 Jul 15;165(2):750-9.

8.

Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons.

Krisky DM, Wolfe D, Goins WF, Marconi PC, Ramakrishnan R, Mata M, Rouse RJ, Fink DJ, Glorioso JC.

Gene Ther. 1998 Dec;5(12):1593-603.

9.

Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications.

Krisky DM, Marconi PC, Oligino TJ, Rouse RJ, Fink DJ, Cohen JB, Watkins SC, Glorioso JC.

Gene Ther. 1998 Nov;5(11):1517-30.

10.

DNA vaccines and immunity to herpes simplex virus.

Rouse BT, Nair S, Rouse RJ, Yu Z, Kuklin N, Karem K, Manickan E.

Curr Top Microbiol Immunol. 1998;226:69-78. Review. No abstract available.

PMID:
9479836
11.

Rapid method for construction of recombinant HSV gene transfer vectors.

Krisky DM, Marconi PC, Oligino T, Rouse RJ, Fink DJ, Glorioso JC.

Gene Ther. 1997 Oct;4(10):1120-5.

12.

Modulation of mucosal and systemic immunity by enteric administration of nonreplicating herpes simplex virus expressing cytokines.

Kuklin NA, Daheshia M, Marconi PC, Krisky DM, Rouse RJ, Glorioso JC, Manican E, Rouse BT.

Virology. 1998 Jan 20;240(2):245-53.

13.

Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells.

Manickan E, Kanangat S, Rouse RJ, Yu Z, Rouse BT.

J Leukoc Biol. 1997 Feb;61(2):125-32.

PMID:
9021916
14.

Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.

Manickan E, Rouse RJ, Yu Z, Wire WS, Rouse BT.

J Immunol. 1995 Jul 1;155(1):259-65.

PMID:
7602102
15.

Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses.

Nair S, Buiting AM, Rouse RJ, Van Rooijen N, Huang L, Rouse BT.

Int Immunol. 1995 Apr;7(4):679-88.

PMID:
7547695
16.

Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP 27.

Manickan E, Yu Z, Rouse RJ, Wire WS, Rouse BT.

Viral Immunol. 1995;8(2):53-61.

PMID:
8825290
17.

Supplemental Content

Loading ...
Support Center